{"title":"Relationship of Smoking Risk Factors and Comorbids with Covid-19 Mortality: Systematic Review and Meta-Analysis","authors":"Nindi Elfiza, D. Djafri, A. Putri","doi":"10.24893/jkma.v16i1.898","DOIUrl":null,"url":null,"abstract":"The rapid and uncontrolled transmission of COVID-19, causes the high morbidity and mortality rates of COVID-19 throughout the world, including West Sumatra (CFR 2.27%). This study aims to analyze the mortality of COVID-19 in West Sumatra and the risk factors that influence it. The research design retrospective cohort using secondary data on COVID-19 cases in West Sumatra from March 26, 2020 to June 7, 2021. The sampling technique is total sampling provided that the sample criteria are met. Data analysis used logistic regression method. 44,693 confirmed cases of COVID-19, 968 (2.17%) died and 43,725 (97.83%) did not die. Factors associated with COVID-19 mortality were age (RR 9.79; 95% CI 8.65-11.09), gender (RR 1.51; 95% CI 1.33-1.71), diabetes (RR 10.21; 95% CI 8.91-11.69), hypertension (RR 6.49; 95% CI 5.59-7.54), cardiovascular diseases (RR 9.57; 95% CI 8.17-11.21), COPD (RR 10.51; 95% CI 7.57-14.57), asthma (RR 2.03; 95% CI 1.23-3.34), and kidney diseases (RR 19.87; 95% CI 16.54-23.86). Kidney diseases are the most dominant factor associated with COVID-19 mortality (RR 16.07; 95% CI 11.34-22.78). COVID-19 patients with kidney disease have the highest risk of death. Treatment of patients with comorbidities must be prioritized and improve health promotion in at-risk groups.","PeriodicalId":55665,"journal":{"name":"JKMA Jurnal Kesehatan Masyarakat Andalas Andalas Journal of Public Health","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JKMA Jurnal Kesehatan Masyarakat Andalas Andalas Journal of Public Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24893/jkma.v16i1.898","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The rapid and uncontrolled transmission of COVID-19, causes the high morbidity and mortality rates of COVID-19 throughout the world, including West Sumatra (CFR 2.27%). This study aims to analyze the mortality of COVID-19 in West Sumatra and the risk factors that influence it. The research design retrospective cohort using secondary data on COVID-19 cases in West Sumatra from March 26, 2020 to June 7, 2021. The sampling technique is total sampling provided that the sample criteria are met. Data analysis used logistic regression method. 44,693 confirmed cases of COVID-19, 968 (2.17%) died and 43,725 (97.83%) did not die. Factors associated with COVID-19 mortality were age (RR 9.79; 95% CI 8.65-11.09), gender (RR 1.51; 95% CI 1.33-1.71), diabetes (RR 10.21; 95% CI 8.91-11.69), hypertension (RR 6.49; 95% CI 5.59-7.54), cardiovascular diseases (RR 9.57; 95% CI 8.17-11.21), COPD (RR 10.51; 95% CI 7.57-14.57), asthma (RR 2.03; 95% CI 1.23-3.34), and kidney diseases (RR 19.87; 95% CI 16.54-23.86). Kidney diseases are the most dominant factor associated with COVID-19 mortality (RR 16.07; 95% CI 11.34-22.78). COVID-19 patients with kidney disease have the highest risk of death. Treatment of patients with comorbidities must be prioritized and improve health promotion in at-risk groups.
COVID-19的快速和不受控制的传播导致包括西苏门答腊在内的世界各地COVID-19的高发病率和死亡率(CFR 2.27%)。本研究旨在分析西苏门答腊COVID-19的死亡率及其影响因素。本研究利用2020年3月26日至2021年6月7日西苏门答腊COVID-19病例的二手数据设计回顾性队列。采样技术是在满足采样标准的情况下进行全采样。数据分析采用logistic回归方法。确诊病例44693例,死亡968例(2.17%),未死亡43725例(97.83%)。与COVID-19死亡率相关的因素是年龄(RR 9.79;95% CI 8.65-11.09),性别(RR 1.51;95% CI 1.33-1.71),糖尿病(RR 10.21;95% CI 8.91-11.69),高血压(RR 6.49;95% CI 5.59-7.54),心血管疾病(RR 9.57;95% ci 8.17-11.21), copd (rr 10.51;95% CI 7.57-14.57),哮喘(RR 2.03;95% CI 1.23-3.34),肾脏疾病(RR 19.87;95% ci 16.54-23.86)。肾脏疾病是与COVID-19死亡率相关的最主要因素(RR 16.07;95% ci 11.34-22.78)。COVID-19肾病患者的死亡风险最高。必须优先考虑有合并症患者的治疗,并改善高危人群的健康促进。